Newswise — ORLANDO, Fla. — The AACR would like to congratulate its newest grant recipients at the AACR 102nd Annual Meeting 2011, held April 2-6.
Grant details and recipients are detailed below.
FELLOWSHIPS:
AACR-Amgen, Inc. Fellowships in Clinical/Translational Cancer Research • Takashi Kobayashi, M.D., Ph.D., Columbia University Medical CenterNovel therapeutic targets in invasive bladder cancer• Kun Wang, Ph.D., University of Kansas Medical Center Research Institute, Inc.Inhibition of RalA as a novel strategy for targeting ovarian cancer
AACR Anna D. Barker Fellowship in Basic Cancer Research• Daniel Schramek, Ph.D., The Rockefeller UniversityIn vivo RNAi screen to identify regulators of skin tumorigenesis
AACR-Astellas Pharma Global Development, Inc. Fellowship in Basic Cancer Research • Caroline Kumsta, Ph.D., Sanford-Burnham Medical Research Institute Translational control of tumor formation in C. Elegans
AACR-Astellas USA Foundation Fellowship in Basic Cancer Research • Jae Park, M.D., Memorial Sloan-Kettering Cancer CenterModulating tumor microenvironment with genetically modified T cells
AACR-Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research• Randall J. Kimple, M.D., Ph.D., University of Wisconsin-MadisonHuman papillomavirus modulation of head and neck cancer radiation response
AACR Judah Folkman Fellowship for Anti-Angiogenesis Research • Arnab Ghosh, M.D., Ph.D., Sloan-Kettering Institute for Cancer ResearchNeovascularization in GVHD and growth of tumors in recipients of allo-BMT
Fight Colorectal Cancer-AACR Fellowship, in memory of Lisa Dubow• Jon H. Chung, Ph.D., Johns Hopkins University School of MedicineHedgehog pathway targeted therapeutics for metastatic colorectal cancer
FELLOWS GRANT:
AACR-FNAB Fellows Grant for Translational Pancreatic Cancer Research• Xiaoqun Dong, M.D., Ph.D., The University of Texas MD Anderson Cancer CenterNR5A2/LRH1 as a potential therapeutic target of pancreatic cancer
CAREER DEVELOPMENT AWARDS:
AACR-Genentech BioOncology Career Development Award for Cancer Research on the HER Family Pathway • Vassiliki Karantza, M.D., Ph.D., UMDNJ-Robert Wood Johnson Medical SchoolAutophagy and HER2 interactions in breast cancer progression and treatment
AACR Gertrude B. Elion Cancer Research Award• Yali Dou, Ph.D., University of MichiganTargeting MLL in acute myeloid leukemia (2010)• Charles G. Mullighan, M.D., St. Jude Children’s Research HospitalExome sequencing of hypodiploid acute lymphoblastic leukemia (2011)
SUPPLEMENTAL GRANT:
AACR Dharma Master Jiantai Innovative Grant for Lung Cancer Research• Katrina A. Steiling, M.D., M.Sc., Boston University School of MedicineAirway genomics for the early detection of lung cancer
INDEPENDENT INVESTIGATOR GRANTS:
Breast Cancer Research Foundation-AACR Grants for Translational Breast Cancer Research • Carey Anders, M.D., University of North Carolina Chapel HillPARP inhibition and nanoparticles to treat breast cancer brain metastases• Heide L. Ford, Ph.D., University of Colorado DenverTargeting the Six1/Eya complex for anti-breast cancer metastasis therapies
# # #
Press registration for the AACR 102nd Annual Meeting 2011 is free to qualified journalists and public information officers: http://www.aacr.org/PressRegistration.
Follow the AACR on Twitter: @aacr #AACRFollow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.
RSS